SCHEMBL8856609

SCHEMBL8856609

O=C(NN=c1c(=O)c2ccccc2c1=O)c1ccc(F)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.79
ALDH1A1 P00352 5/20 0.79
KMT2A Q03164 4/20 0.79
SENP6 Q9GZR1 3/20 0.79
MAPT P10636 3/20 0.79
CASP3 P42574 2/20 0.79
SENP8 Q96LD8 2/20 0.79
SENP7 Q9BQF6 2/20 0.79
APAF1 O14727 1/20 0.79
TDP2 O95551 1/20 0.79
CYP1A2 P05177 1/20 0.79
CYP2D6 P10635 1/20 0.79
THRB P10828 1/20 0.79
CYP2C9 P11712 1/20 0.79
CYP2C19 P33261 1/20 0.79
KDM4E B2RXH2 3/20 0.50
AURKA O14965 1/20 0.49
MEN1 O00255 3/20 0.49
PPARG P37231 1/20 0.46
NCOA2 Q15596 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8856654 0.88 ALDH1A1 (1.00) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856709 0.87 KMT2A (0.79) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856739 0.86 KMT2A (0.77) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856632 0.86 KMT2A (0.77) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856828 0.83 SENP6 (1.00) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856794 0.82 SENP6 (1.00) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856780 0.81 MAPT (0.68) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856430 0.81 KMT2A (0.63) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL8856682 0.80 SENP6 (0.68) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT
SCHEMBL9004670 0.80 MAPT (0.55) SMN1; SMN2ALDH1A1KMT2ASENP6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5648381-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1997-07-15 US disclosed
EP-0566446-B1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566446-A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020046-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR PREPARATION OF SAME AND THEIR USE AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed